Table 1.

Clinical demographics of patient cohort.

Patient Clinical Parameters
Diagnosis	OAC = 13 OGJ = 19
Sex	Male = 21 Female = 11
Obesity Status via Visceral Fat Area	Obese = 16 Non-obese = 16
Age at diagnosis	51–83 (Mean = 67.83)
Post-treatment BMI	22.34–43 (Mean = 32.391) Non-obese Mean = 28.4, Obese Mean = 30.025 Male Mean = 40.282, Female Mean = 29.822
Weight	57.2–176 kg (Mean = 86.697) Non-obese Mean = 82.865, Obese Mean = 94.093 Male Mean = 94.72, Female Mean = 76.79
Mean VFA	22.9–485.2 (Mean = 139.404) Non-obese Mean = 115.192, Obese Mean = 167.1 Male Mean = 148.436, Female Mean = 122.872
Metabolic Dysfunction	n = 15
High cholesterol or intervention for high cholesterol	n = 21
High blood pressure or intervention for high blood pressure	n = 20
High Triglycerides or intervention for high Triglycerides	n = 4
Diabetes	n = 10
Barrett’s oesophagus	n = 17
ASA grade (risk-stratifying system to help predict preoperative risks)	Grade 1 → n = 3
	Grade 2 → n = 15
	Grade 3 → n = 10
Clavien–Dindo classification (grading for adverse events which occur as a result of surgical procedures)	Classification 0 → n = 5 Classification 1 → n = 4 Classification 2 → n = 7 Classification 3 → n = 7 Classification 4 → n = 5
Treatment	Naïve → n = 10 FLOT → n = 14 CROSS → n = 8
Tumour Regression Grading (TRG)	TRG 1 → n = 3 (CROSS n = 2, FLOT n = 1) TRG 2 → n = 3 (CROSS n = 1, FLOT n = 2) TRG 3 → n = 8 (CROSS n = 3, FLOT n = 5) TRG 4 → n = 3 (CROSS n = 2, FLOT n = 1) TRG 5 → n = 3 (CROSS n = 0, FLOT n = 3)
Clinical Stage (T)	T1 → n = 10 T2 → n = 3 T3 → n = 19
Clinical Stage (N)	N0 → n = 17 N1 → n = 8 N2 → n = 7
Path stage (T)	T0 → n = 3 T1 → n = 9 T2 → n = 4 T3 → n = 13 T4 → n = 3
Path Stage (N)	N0 → n = 17 N1 → n = 6 N2 → n = 6 N3 → n = 3
Perineural Invasion	n = 9
Lymph Involvement	n = 17
Vascular Involvement	n = 11
Evidence of Disease	n = 10